CONMED (CNMD) CFO converts 7,500 RSUs; 2,164 shares withheld

CONMED Corp (CNMD) insider transaction: Executive Vice President & CFO Todd W. Garner reported RSU-related activity on 10/31/2025.

Rhea-AI Filing Summary

CONMED Corp (CNMD) insider transaction: Executive Vice President & CFO Todd W. Garner reported RSU-related activity on 10/31/2025. He acquired 7,500 shares of common stock at $0 upon settlement of restricted stock units (transaction code M), then had 2,164 shares withheld at $44 per share for taxes (code F).

After these transactions, he holds 5,336 shares directly. He also reports 15,227 RSUs as derivative securities beneficially owned following the transactions. Each RSU represents a right to receive one share of common stock. The RSUs are under the Company’s 2018 Long‑Term Incentive Plan, vesting over two years with 33% after year 1 and 67% after year 2.

Insider Trade Summary

7,500 shares exercised/converted

Exercise 3 txns

Insider Garner Todd W

Role Executive Vice President & CFO

Type	Security	Shares	Price	Value
Exercise	RSUs (Restricted Stock Units)	7,500	$0.00	$0.00
Exercise	Common Stock	7,500	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,164	$44.00	$95K

Holdings After Transaction: RSUs (Restricted Stock Units) — 15,227 contracts (Direct); Common Stock — 5,336 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company").
2. F2. The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CONMED (CNMD) report in this Form 4?

Todd W. Garner, EVP & CFO, settled RSUs into 7,500 common shares (code M) and had 2,164 shares withheld at $44 for taxes (code F) on 10/31/2025.

How many CNMD shares does the reporting person own after the transaction?

He directly owns 5,336 common shares following the reported transactions.

How many RSUs are reported after the transaction?

He reports 15,227 RSUs as derivative securities beneficially owned following the transactions.

What are the vesting terms of the RSUs for CNMD?

Under the 2018 Long‑Term Incentive Plan, RSUs vest over two years: 33% after year 1 and 67% after year 2.

What was the tax withholding related to the RSU settlement?

A disposition of 2,164 shares at $44 per share (code F) was reported for tax withholding.

Who is the reporting person and their role at CONMED?

The reporting person is Todd W. Garner, Executive Vice President & Chief Financial Officer of CONMED Corp.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/03/2025 - 04:47 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Garner Todd W

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FL 33773

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President & CFO

3. Date of Earliest Transaction (Month/Day/Year)
10/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/31/2025		M		7,500	A	$0	7,500	D
Common Stock	10/31/2025		F		2,164	D	$44	5,336	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
RSUs (Restricted Stock Units)	(1)	10/31/2025		M			7,500	(2)	(2)	Common Stock	7,500	$0	15,227	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company").

2. The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2.

	/s/ Thomas Fistek for Todd W. Garner by Power of Attorney	11/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.